Erratum: "The first generic tirzepatide GP30931: physicochemical and biological similarity to the reference drug"
https://doi.org/10.33380/2305-2066-2026-15-1-249-250
Abstract
Drug development & registration. 2025;14(2):54–74. (In Russ.) https://doi.org/10.33380/2305-2066-2025-14-2-2084. Published: 20.05.2025.
About the Authors
I. A. LugovikRussian Federation
A. V. Babina
Russian Federation
S. S. Arutyunyan
Russian Federation
D. О. Ermolaeva
Russian Federation
V. B. Saparova
Russian Federation
T. N. Kobeleva
Russian Federation
P. G. Zaikin
Russian Federation
A. D. Mikushina
Russian Federation
A. S. Bukatin
Russian Federation
I. E. Eliseev
Russian Federation
B. Ts. Zajchik
Russian Federation
Y. S. Keruchenko
Russian Federation
I. S. Ohrimenko
Russian Federation
E. V. Bocharov
Russian Federation
A. Kh. Taldaev
Russian Federation
V. A. Lushpa
Russian Federation
I. E. Makarenko
Russian Federation
R. V. Drai
Russian Federation
Review
For citations:
Lugovik I.A., Babina A.V., Arutyunyan S.S., Ermolaeva D.О., Saparova V.B., Kobeleva T.N., Zaikin P.G., Mikushina A.D., Bukatin A.S., Eliseev I.E., Zajchik B.Ts., Keruchenko Y.S., Ohrimenko I.S., Bocharov E.V., Taldaev A.Kh., Lushpa V.A., Makarenko I.E., Drai R.V. Erratum: "The first generic tirzepatide GP30931: physicochemical and biological similarity to the reference drug". Drug development & registration. 2026;15(1):249-250. (In Russ.) https://doi.org/10.33380/2305-2066-2026-15-1-249-250
JATS XML


































